Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-05 11:41 am Sale | 2026-05-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | T. Rowe Price Associates, Inc. | 586,990 2.200% | -2,254,124![]() (-79.34%) | Filing History |
| 2026-05-20 5:05 pm Purchase | 2026-05-18 | 13G | TENAX THERAPEUTICS INC PAR TENX | Millennium Management LLC | 1,347,130 5.100% | 1,347,130![]() (New Position) | Filing History |
| 2026-05-15 6:55 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Logos Global Management LP | 800,000 3.000% | 185,000![]() (+30.08%) | Filing History |
| 2026-05-15 5:26 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Stonepine Capital Management, LLC | 975,200 3.700% | 602,403![]() (+161.59%) | Filing History |
| 2026-05-15 4:31 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Venrock Healthcare Capital Partners III, L.P. | 1,955,105 9.900% | 1,262,146![]() (+182.14%) | Filing History |
| 2026-05-15 4:30 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Point72 Asset Management, L.P. | 533,965 3.100% | 110,550![]() (+26.11%) | Filing History |
| 2026-05-15 4:14 pm Sale | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Lind Global Fund II LP | 202,480 0.780% | -240,000![]() (-54.24%) | Filing History |
| 2026-05-15 4:13 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | BIOTECHNOLOGY VALUE FUND L P | 1,908,722 9.990% | 1,140,522![]() (+148.47%) | Filing History |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Perceptive Advisors LLC | 1,447,782 5.500% | 878,474![]() (+154.31%) | Filing History |
| 2026-05-15 10:35 am Sale | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Dellora Investments Master Fund LP | 394,665 2.300% | -6,406![]() (-1.60%) | Filing History |
| 2026-05-15 08:38 am Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | RTW Investments, LP | 1,867,630 9.900% | 1,216,662![]() (+186.90%) | Filing History |
| 2026-05-08 6:19 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Integrated Core Strategies (US) LLC | 533,889 2.100% | 220,177![]() (+70.18%) | Filing History |
| 2026-05-07 11:04 am Sale | 2026-04-30 | 13G | TENAX THERAPEUTICS INC PAR TENX | T. Rowe Price Associates, Inc. | 2,841,114 11.000% | -110,002![]() (-3.73%) | Filing History |
| 2026-05-07 10:31 am Sale | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | T. Rowe Price Associates, Inc. | 2,951,116 17.200% | -798,884![]() (-21.30%) | Filing History |
| 2026-05-04 2:46 pm Unchanged | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Invus Global Management, LLC | 427,141 2.500% | 0 (Unchanged) | Filing History |
| 2026-04-08 6:26 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Morgan Stanley MS | 596,564 3.500% | 188![]() (+0.03%) | Filing History |
| 2026-04-07 9:34 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Ikarian Capital, LLC | 1,145,100 6.700% | 177,500![]() (+18.34%) | Filing History |
| 2026-03-10 6:02 pm Purchase | 2025-12-10 | 13D | TENAX THERAPEUTICS INC PAR TENX | Christopher Thomas Giordano | 1,252,965 6.790% | 1,252,965![]() (New Position) | Filing History |
| 2026-03-09 12:24 pm Purchase | 2026-02-27 | 13G | TENAX THERAPEUTICS INC PAR TENX | Logos Global Management LP | 615,000 9.900% | 615,000![]() (New Position) | Filing History |
| 2026-02-17 6:20 pm Purchase | 2025-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Venrock Healthcare Capital Partners III, L.P. | 692,959 9.900% | 139,989![]() (+25.32%) | Filing History |

